Safety, Tolerability, and PK of AH-008 Following Single Ascending Dose in Healthy Subjects

Clinical trial NCT07697560 · RECRUITING

Trial details

NCT number: NCT07697560
Sponsor: AnHorn Medicines Co. Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Chemotherapy-induced Peripheral Neuropathy (CIPN)

Start date: 2026-06-10
Primary completion: 2026-09-01
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.